Given the increasing focus on cardiovascular long-term effects of COVID-19, this study seeks to elucidate the potential connection between alterations in PROS1 plasma levels and the concomitant presence of the virus within cardiovascular tissues, following past or ongoing SARS-CoV-2 infection. This evidence concerns the gene PROS1 and COVID-19.